A Groundbreaking Therapy with Tzield Ft. Special Guest Sierra Werling
In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with Sierra Werling, their first patient to ever receive Tzield, to discuss the groundbreaking therapy designed to delay the onset of type 1 diabetes. Sierra shares her personal journey, how she discovered she was at risk for type 1, what led her to pursue the Tzield treatment, and how her life has changed since receiving it. Steve and Jeremy also break down the science behind Tzield, how it works to preserve insulin-producing beta cells, and why early screening for type 1 diabetes is more important than ever. They discuss how delaying the disease can impact long-term health, providing individuals more time to prepare, access new treatments, and potentially reduce complications in the future. This episode highlights a major shift in diabetes care, one that moves beyond just managing type 1 diabetes to proactively delaying its onset. Tune in to hear Sierra’s experience, insights, and what this means for the future of diabetes prevention.Key Topics:What is Tzield, and how does it work to delay type 1 diabetes?Sierra’s journey: From early screening to Tzield infusionUnderstanding the stages of type 1 diabetes, where does Tzield fit in?How delaying type 1 diabetes impacts long-term health and quality of lifeThe emotional and practical benefits of early T1D interventionWhy screening for type 1 diabetes is critical, even without a family historySierra’s personal insights, what she learned from the process, and what she wants others to knowWhat’s next for Tzield and other potential disease-modifying therapies?Screen today: https://www.screenfortype1.com/ ★ Support this podcast ★